Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 151–165 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3047 BMP2 Gene Brachydactyly Type A2 Genetic Test This test identifies pathogenic variants within the BMP2 gene associated with autosomal dominant brachydactyly type A2.	Peripheral Whole Blood (EDTA) or DNA FTA Card	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMP2 gene variants", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of brachydactyly type A2", "Family history of brachydactyly", "Need for genetic counseling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 82316-9 ICD-10: Q68.1 Clinical summary This test identifies pathogenic variants within the BMP2 gene associated with autosomal dominant brachydactyly type A2.
TEST-1911 BMPR1A Gene Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2) Genetic Test This genetic test evaluates the BMPR1A gene for pathogenic variants associated with Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2), a condition increasing colorectal cancer ris...	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMPR1A gene sequence", "Copy Number Variants (CNVs) in BMPR1A"] Parameters [] Preparation ["No fasting required", "Complete pre-genetic counselling session", "Sign informed consent"] Indications ["Personal or family history of multiple and/or mixed gastrointestinal polyps", "Early-onset colorectal cancer", "Known familial BMPR1A mutation"] Measurement technique Confirm with laboratory Codes LOINC: 21634-2 ICD-10: Z15.09 Clinical summary This genetic test evaluates the BMPR1A gene for pathogenic variants associated with Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2), a condition increasing colorectal cancer risk.
TEST-5232 BOLA3 Gene-MMDS2 Genetic Test This test analyzes the BOLA3 gene for pathogenic variants associated with Multiple Mitochondrial Dysfunctions Syndrome Type 2 (MMDS2). It uses Next Generation Sequencing (NGS) to c...	Peripheral whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BOLA3 gene", "Coding exons ± 20 bp intronic boundaries of the BOLA3 gene"] Parameters [] Preparation ["No specific fasting required.", "No medication or diet modifications needed prior to sample collection."] Indications ["Definitive diagnosis of MMDS2", "Carrier screening for MMDS2", "Informed family planning", "Differential diagnosis of mitochondrial encephalomyopathies"] Measurement technique Confirm with laboratory Codes LOINC: 89588-6 ICD-10: G31.89 Clinical summary This test analyzes the BOLA3 gene for pathogenic variants associated with Multiple Mitochondrial Dysfunctions Syndrome Type 2 (MMDS2). It uses Next Generation Sequencing (NGS) to cover the entire coding region.
TEST-4363 BRAF Gene Cardiofaciocutaneous Syndrome Genetic Test This test evaluates the entire coding region of the BRAF gene for pathogenic variants associated with Cardiofaciocutaneous Syndrome (CFC). It uses Next-Generation Sequencing (NGS)...	Peripheral Whole Blood or Buccal Swab (DNA Extraction)	3–4 Weeks (expedited processing available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF gene coding region variants", "Pathogenic mutations associated with CFC"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications"] Indications ["Suspected Cardiofaciocutaneous Syndrome (CFC)", "RASopathy suspected with negative prior testing", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 81263-1 ICD-10: Q87.89 Clinical summary This test evaluates the entire coding region of the BRAF gene for pathogenic variants associated with Cardiofaciocutaneous Syndrome (CFC). It uses Next-Generation Sequencing (NGS) with Sanger confirmation.
TEST-450 Breast Monitor Panel Test This diagnostic test evaluates three key tumor markers (CA 15-3, CEA, CA 27.29) in serum to monitor patients with a history of breast cancer for recurrence or response to treatment...	Serum	Daily reporting — results available within 24 hours of sample collection	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA 15-3", "CEA (Carcinoembryonic Antigen)", "CA 27.29"] Parameters [{"name": "CA 15-3", "reference_range": null}, {"name": "CEA", "reference_range": null}, {"name": "CA 27.29", "reference_range": null}] Preparation ["No special preparation required", "No fasting needed", "No dietary changes needed", "No medication adjustments needed unless instructed by physician"] Indications ["Monitoring for recurrence in patients with a history of breast cancer", "Assessing response to breast cancer therapy", "Longitudinal trend analysis in follow-up care"] Measurement technique Confirm with laboratory Codes LOINC: 24025-5 ICD-10: Z08.0 Clinical summary This diagnostic test evaluates three key tumor markers (CA 15-3, CEA, CA 27.29) in serum to monitor patients with a history of breast cancer for recurrence or response to treatment.
TEST-458 Bromide Total Test This diagnostic test evaluates the concentration of bromide in the patient's serum.	Serum	3–4 weeks (batch tested)	1,900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Bromide Level"] Parameters [{"name": "Bromide Total", "reference_range": null}] Preparation ["Avoid bromide-containing supplements or sedatives for 48 hours prior, unless medically contraindicated.", "A duly filled Test Send Out Consent Form (Form 35) is mandatory before sample collection."] Indications ["Therapeutic drug monitoring for bromide therapy", "Management of epilepsy", "Monitoring neurological conditions"] Measurement technique Confirm with laboratory Codes LOINC: 14314-1 ICD-10: Z79.8, G40.9 Clinical summary This diagnostic test evaluates the concentration of bromide in the patient's serum.
TEST-6067 BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test This test evaluates the BSCL2 gene for pathogenic variants associated with congenital generalized lipodystrophy type 2.	Peripheral whole blood (3–5 mL EDTA) or FTA card	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSCL2 gene", "Coding region and splice-site variants", "SNVs, indels, and splice-site variants down to 5% heteroplasmy"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed metabolic therapy without consulting physician"] Indications ["Patients presenting with severe insulin resistance", "Patients with hypertriglyceridemia", "Patients with early-onset metabolic complications", "Suspected congenital generalized lipodystrophy type 2"] Measurement technique Confirm with laboratory Codes LOINC: 21659-0 ICD-10: E88.1 Clinical summary This test evaluates the BSCL2 gene for pathogenic variants associated with congenital generalized lipodystrophy type 2.
TEST-5633 BSCL2 Gene SPG17 Genetic Test This test evaluates the BSCL2 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 17 (SPG17).	Peripheral whole blood (EDTA tube), extracted genomic DNA, or FTA card blood spot	3 to 4 weeks from receipt of specimen	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSCL2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Splice-site alterations"] Parameters [] Preparation ["No fasting required", "No special dietary restrictions", "Mandatory pre-test genetic counselling session"] Indications ["Suspected diagnosis of Hereditary Spastic Paraplegia Type 17", "Family history of SPG17", "Genetic counselling for neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21665-9 ICD-10: G11.4, Z13.71 Clinical summary This test evaluates the BSCL2 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 17 (SPG17).
TEST-3870 BSND Gene (Bartter Syndrome Type 4A) Genetic Test This genetic test analyzes the BSND gene for pathogenic variants associated with Bartter Syndrome Type 4A.	Whole Blood (EDTA) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSND gene"] Parameters [] Preparation ["Prior genetic counselling session", "Documented three-generation pedigree"] Indications ["Suspected Bartter Syndrome Type 4A", "Unexplained hypokalemia", "Unexplained metabolic alkalosis", "Sensorineural hearing loss", "Family history of Bartter Syndrome Type 4A", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81313-4 ICD-10: E26.81 Clinical summary This genetic test analyzes the BSND gene for pathogenic variants associated with Bartter Syndrome Type 4A.
TEST-6039 BTD Gene (Biotinidase Deficiency) Genetic Test This genetic test evaluates the BTD gene for pathogenic variants associated with biotinidase deficiency.	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BTD gene coding region", "Pathogenic variants (SNVs, indels, large rearrangements)"] Parameters [] Preparation ["Prior genetic counselling and clinical history documentation are mandatory", "A pedigree chart must be drawn"] Indications ["Suspected biotinidase deficiency", "Family history of biotinidase deficiency", "Neonates Measurement technique Confirm with laboratory Codes LOINC: 81321-0 ICD-10: E75.22 Clinical summary This genetic test evaluates the BTD gene for pathogenic variants associated with biotinidase deficiency.
TEST-3385 BTK Gene (X-Linked Agammaglobulinemia Type 1) Genetic Test This genetic test identifies mutations in the BTK gene responsible for X-linked agammaglobulinemia (XLA).	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BTK gene mutations", "Copy Number Variations (CNV) in BTK gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion (within 2 weeks)"] Indications ["Suspected X-linked agammaglobulinemia (XLA)", "Recurrent sinopulmonary infections", "Low immunoglobulin levels", "Absent B-cells"] Measurement technique Confirm with laboratory Codes LOINC: 55221-2 ICD-10: D80.0 Clinical summary This genetic test identifies mutations in the BTK gene responsible for X-linked agammaglobulinemia (XLA).
TEST-3351 BTK Gene Agammaglobulinemia and Isolated Hormone Deficiency Genetic Test This genetic test analyzes the BTK gene to detect mutations associated with X-linked agammaglobulinemia and isolated hormone deficiency.	Blood (Peripheral Whole Blood)	14–21 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BTK gene variants", "Copy Number Variations (CNV) in BTK gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions or bone marrow transplants"] Indications ["Suspected X-linked agammaglobulinemia", "Suspected isolated hormone deficiency", "Family history of BTK-related disorders", "Evaluation of borderline immunoglobulin levels"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: D80.0, E23.0, Z14.8 Clinical summary This genetic test analyzes the BTK gene to detect mutations associated with X-linked agammaglobulinemia and isolated hormone deficiency.
TEST-460 Bupropion Test This test quantifies bupropion and hydroxybupropion levels in serum to guide therapeutic drug monitoring.	Serum	2–3 weeks	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Bupropion", "Serum Hydroxybupropion"] Parameters [{"name": "Bupropion", "reference_range": null}, {"name": "Hydroxybupropion", "reference_range": null}] Preparation ["Blood sample must be drawn immediately before the next scheduled dose (trough level).", "Do not take the morning dose prior to collection.", "Continue all other medications as prescribed unless otherwise directed by your physician."] Indications ["Monitoring antidepressant therapy", "Monitoring smoking cessation therapy", "Assessing adherence", "Guiding dose adjustments"] Measurement technique Confirm with laboratory Codes LOINC: 3530-0 ICD-10: Z51.81 Clinical summary This test quantifies bupropion and hydroxybupropion levels in serum to guide therapeutic drug monitoring.
TEST-749 C-Peptide Response to Glucose (5-Hour) Test This diagnostic test evaluates pancreatic beta-cell function and insulin secretion dynamics in response to a glucose challenge.	Serum / Plasma	24 Hours (Same-day batch processing)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C-peptide levels", "Glucose levels", "Insulin secretion dynamics"] Parameters [{"name": "C-Peptide", "reference_range": null}, {"name": "Glucose", "reference_range": null}] Preparation ["Fasting for 8 to 12 hours prior to the test", "Avoid strenuous exercise on the morning of the test"] Indications ["Differentiating type 1 and type 2 diabetes", "Evaluating insulin resistance", "Diagnosing insulinoma", "Diagnosing reactive hypoglycemia"] Measurement technique Confirm with laboratory Codes LOINC: 20448-7 ICD-10: R73.09, E11.9, E16.2 Clinical summary This diagnostic test evaluates pancreatic beta-cell function and insulin secretion dynamics in response to a glucose challenge.
TEST-3302 C15orf41 Gene Congenital Dyserythropoietic Anemia Type 1B (CDAIB) Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants within the C15orf41 gene associated with Congenital Dyserythropoietic Anemia Type 1B (CDAIB).	Whole blood (EDTA), buccal swab, or FTA card	21–28 calendar days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in C15orf41 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number alterations (CNVs)"] Parameters [] Preparation ["No specific preparation required"] Indications ["Suspected congenital dyserythropoietic anemia", "Carrier detection", "Family planning", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21665-5 ICD-10: D61.09 Clinical summary This test identifies pathogenic variants within the C15orf41 gene associated with Congenital Dyserythropoietic Anemia Type 1B (CDAIB).

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories